AMERICAN SUPERCONDUCTOR CORP (AMSC)

US0301112076 - Common Stock

12.42  +0.15 (+1.22%)

Fundamental Rating

3

AMSC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 86 industry peers in the Electrical Equipment industry. While AMSC seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, AMSC is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

AMSC had negative earnings in the past year.
In the past year AMSC has reported a negative cash flow from operations.
AMSC had negative earnings in 4 of the past 5 years.
In the past 5 years AMSC reported 4 times negative operating cash flow.

1.2 Ratios

AMSC has a Return On Assets (-9.86%) which is in line with its industry peers.
AMSC has a Return On Equity (-20.63%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -9.86%
ROE -20.63%
ROIC N/A
ROA(3y)-14.8%
ROA(5y)-7.15%
ROE(3y)-26.6%
ROE(5y)-14.1%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AMSC has a Gross Margin (21.18%) which is comparable to the rest of the industry.
AMSC's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for AMSC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.35%
GM growth 5Y0.42%

4

2. Health

2.1 Basic Checks

AMSC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AMSC has been increased compared to 1 year ago.
AMSC has more shares outstanding than it did 5 years ago.
AMSC has a better debt/assets ratio than last year.

2.2 Solvency

AMSC has an Altman-Z score of -5.22. This is a bad value and indicates that AMSC is not financially healthy and even has some risk of bankruptcy.
AMSC has a worse Altman-Z score (-5.22) than 83.33% of its industry peers.
There is no outstanding debt for AMSC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.22
ROIC/WACCN/A
WACC10.61%

2.3 Liquidity

AMSC has a Current Ratio of 1.29. This is a normal value and indicates that AMSC is financially healthy and should not expect problems in meeting its short term obligations.
AMSC has a Current ratio of 1.29. This is amonst the worse of the industry: AMSC underperforms 80.95% of its industry peers.
AMSC has a Quick Ratio of 1.29. This is a bad value and indicates that AMSC is not financially healthy enough and could expect problems in meeting its short term obligations.
AMSC has a Quick ratio of 0.72. This is amonst the worse of the industry: AMSC underperforms 82.14% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 0.72

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 64.13% over the past year.
Looking at the last year, AMSC shows a very strong growth in Revenue. The Revenue has grown by 31.98%.
AMSC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.97% yearly.
EPS 1Y (TTM)64.13%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q111.11%
Revenue 1Y (TTM)31.98%
Revenue growth 3Y18.44%
Revenue growth 5Y16.97%
Revenue growth Q2Q64.79%

3.2 Future

AMSC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.41% yearly.
Based on estimates for the next years, AMSC will show a quite strong growth in Revenue. The Revenue will grow by 17.59% on average per year.
EPS Next Y93.73%
EPS Next 2Y42.81%
EPS Next 3Y30.41%
EPS Next 5YN/A
Revenue Next Year37.36%
Revenue Next 2Y22.09%
Revenue Next 3Y17.59%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

AMSC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 304.41, AMSC can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, AMSC is valued a bit cheaper than the industry average as 61.90% of the companies are valued more expensively.
AMSC is valuated expensively when we compare the Price/Forward Earnings ratio to 21.35, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 304.41

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
AMSC's earnings are expected to grow with 30.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.81%
EPS Next 3Y30.41%

0

5. Dividend

5.1 Amount

AMSC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMERICAN SUPERCONDUCTOR CORP

NASDAQ:AMSC (4/29/2024, 8:34:22 AM)

12.42

+0.15 (+1.22%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap448.86M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 304.41
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.86%
ROE -20.63%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 21.18%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.29
Quick Ratio 0.72
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)64.13%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y93.73%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)31.98%
Revenue growth 3Y18.44%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y